| Component: (Network and Table) | |
|---|---|
| Network | 00500 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (http://www.adhc.com/role/StatementConsolidatedStatementsOfCashFlows)  | 
| Table | (Implied) | 
| Reporting Entity [Axis] | 0001602367 (http://www.sec.gov/CIK) | 
| Statement of Cash Flows [Abstract] | Period [Axis] | ||
|---|---|---|---|
2015-01-01 - 2015-12-31  | 2014-01-01 - 2014-12-31  | 2013-01-01 - 2013-12-31  | |
Statement of Cash Flows [Abstract]  | |||
Cash flows from operating activities:  | |||
Net income (loss)  | 32,823,000    | (17,272,000)   | (2,984,000)   | 
Adjustments to reconcile net income (loss) to net cash used in operating activities:  | |||
Loss (gain) from the disposal or impairment of assets  | (  | ||
Realized loss on derivative  | (  | ||
Depreciation and amortization  | 17,875,000    | 15,037,000    | 7,920,000    | 
Deferred tax benefit  | (  | ||
Amortization of deferred loan costs  | |||
Write-off of deferred loan costs  | |||
Provision for bad debts  | 70,119,000    | 32,624,000    | 12,077,000    | 
Gain on contribution to unconsolidated joint venture  | (24,250,000)   | xsi:nil    | xsi:nil    | 
Equity in earnings (loss) of unconsolidated joint venture  | (8,927,000)   | 900,000    | |
Distribution from unconsolidated joint venture  | |||
Stock-based compensation  | |||
Changes in operating assets and liabilities:  | |||
Restricted cash  | (  | (  | |
Accounts receivable  | (  | (  | (  | 
Other receivables and current assets  | (  | (  | (  | 
Medical supplies inventory  | (  | (  | (  | 
Other long-term assets  | (  | (  | |
Accounts payable and accrued expenses  | |||
Accrued compensation  | |||
Deferred rent  | |||
Net cash provided by (used in) operating activities  | (  | ||
Cash flows from investing activities:  | |||
Investment in unconsolidated joint venture  | (  | ||
Deposits  | (  | (  | |
Proceeds from sale of property and equipment  | |||
Capital expenditures  | (  | (  | (  | 
Net cash used in investing activities  | (  | (  | (  | 
Cash flows from financing activities:  | |||
Proceeds from initial public offering, net of underwriters fees and expenses  | |||
Purchase of limited liability units from LLC Unit holders  | (  | ||
Proceeds from long-term borrowings  | |||
Payment of deferred loan costs  | (  | (  | (  | 
Payments on borrowings  | (  | (  | (  | 
Payment of capital lease obligations  | (  | (  | (  | 
Payment to terminate interest rate swap  | (  | ||
Payments of dividends  | (  | ||
Tax distribution to LLC Unit holders  | (3,543,000)   | (9,000)   | (33,000)   | 
Restricted stock forfeited on vesting to satisfy withholding requirements  | (238,000)   | ||
Contribution from original owner  | |||
Net cash provided by financing activities  | |||
Net increase (decrease) in cash and cash equivalents  | (  | ||
Cash, beginning of period  | |||
Cash, end of period  | 2,002,000    | 11,495,000    | |